Inhibikase Therapeutics Inc

The current institutional shareholding score of Inhibikase Therapeutics Inc is 7.00, ranking 80 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 78.17%, representing a quarter-over-quarter increase of 46.41%. The largest institutional shareholder is Frank Sands, holding a total of 12.86M shares, representing 7.64% of shares outstanding, with 36.96% decrease in holdings.